Healthcare M&A Watch 2014 Q4 Report Highlights
After a weak showing in Q3, total deal value rose 96% in Q4 2014
- The total value of pending and concluded mergers and acquisitions rose to $118.7 billion, almost doubling Q2's anemic $60.7 billion.
- Four of the top five deals in Q4 2014 involved Pharma and biotech firms. The biggest: Actavis' $66 billion offer for Allergan.
- Pending and completed deal value in the provider sector climbed to $23.4 billion in Q4 2014, up 5.9% from Q3 2014
- Deal volume continued to slip, with 279 deals in Q4 2014 compared to the 285 deals in Q3 2014 and 287 deals in Q2 2014, the high for the year
Q: What is Healthcare M&A Watch?
A: Healthcare M&A Watch is a digital report produced on a quarterly basis that covers trending and analysis of U.S. mergers and acquisitions among providers, payers, vendors and pharma/life sciences sectors of the healthcare industry. You can purchase the quarterly report individually for $199.
Q: I have a paid ModernHealthcare.com subscription. Can I get the Healthcare M&A Watch for free?
A: Yes, if you are a Premium Web subscriber. Premium Web subscribers have access to all the By The Numbers PDFs and research from Modern Healthcare Insights that are uploaded to our Healthcare Business Data Center.